Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

الشركة الدولية للدواء - pharma international company - b-sitosterol 0.075 g/30gm, radix scutellaria crude powder 0.45 g/30gm, cortex phellodendri crude powder 0.45 g/30gm, rhizoma coptidis crude powder 0.3 g/30gm - 0.075 g/30gm, 0.45 g/30gm, 0.45 g/30gm, 0.3 g/30gm

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

الشركة المتحدة لصناعة الأدوية - united pharmaceutical manufacturing co. ltd. - b-sitosterol 0.075 gm/30gm - 0.075 gm/30gm

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية الشرق شخشير - orient drug store co - miocamycin 6 gm/30gm - 6 gm/30gm

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

4 farmers australia pty ltd - sodium fluoroacetate - liquid concentrate - sodium fluoroacetate mineral-fluorine active 30.0 g/l - vertebrate poison

Australia - English - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - normal immunoglobulin, quantity: 30 g - injection, solution - excipient ingredients: glycine; water for injections - kiovig administered intravenously is indicated for:,1. replacement therapy indications,? primary immunodeficiency disorders (pid);,? symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.,2. immunomodulation indications,? idiopathic thrombocytopenia purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;,? guillain barr? syndrome;,? kawasaki disease;,? chronic inflammatory demyelinating polyradiculoneuropathy (cidp) in adults.,? multifocal motor neuropathy (mmn).,kiovig administered subcutaneously is indicated for:,1. replacement therapy indications,? primary immunodeficiency disorders (pid).

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

nichi-iko pharmaceutical co.,ltd - isosorbide - brown jelly

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة دار الدواء للتنمية والأستثمار - dar al dawa development and investment co ltd - chlorpheniramine maleate 0.025 g/100ml, ephedrine hcl 0.15 g/100ml, guaiphensin 1 g/100ml, dextromethorphan hbr 0.30 g/100ml - 0.025 g/100ml, 0.15 g/100ml, 1 g/100ml, 0.30 g/100ml

Australia - English - Department of Health (Therapeutic Goods Administration)

octapharma australia pty ltd - human immunoglobulin g, quantity: 30 g - injection, intravenous infusion - excipient ingredients: human immunoglobulin a; water for injections; glycine - replacement therapy in:,? primary immunodeficiency diseases.,? myeloma or chronic lymphatic leukaemia with severe secondary hypogammaglobulinaemia and recurrent bacterial infections.,? symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.,immunomodulation in:,? idiopathic thrombocytopenic purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count.,? guillain barr? syndrome.,? kawasaki disease.

India - English - Central Drugs Standard Control Organization

albert d. - dextrose,sod.chl.,pot.chl.,sod.cit.,mag.sulph.,sod.acid phosphate,cal.lactate - pow - 30g.,0.365%,2.33%,1.839%,0.736%,0.975%,0.545% - 30g sac

India - English - Central Drugs Standard Control Organization

psycorem - permethrin - lot - 30g - 30g